Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control
暂无分享,去创建一个
D. Tweedie | R. Walsky | N. Hariparsad | M. Mohutsky | S. Dallas | B. Jones | J. Kenny | Liangfu Chen | D. Ramsden | O. Fahmi | M. Sinz | J. Palamanda | S. Balani | David B. Buckley | H. Einolf | Y. Siu | J. Dekeyser | M. Pardon | George Zhang | Y. A. Siu